BCLI
Brainstorm Cell Therapeutics, Inc.

6,188
Loading...
Loading...
Brainstorm Cell Therapeutics, Inc. is a biotechnology company, which develops and commercializes autologous cellular therapies for the treatment of neurodegenerative diseases, including Amyotrophic Lateral Sclerosis, Progressive Multiple Sclerosis, Alzheimer's disease, and other neurodegenerative diseases. Its pipeline, NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem cells to secrete high levels of neurotrophic factors, modulate neuroinflammatory and neurodegenerative disease processes, promote neuronal survival, and improve neurological function. The company was founded by Irit Arbel on September 22, 2000 and is headquartered in New York, NY.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
27

Frequently Asked Questions

What is Market Cap of Brainstorm Cell Therapeutics, Inc.?
What is the 52-week high for Brainstorm Cell Therapeutics, Inc.?
What is the 52-week low for Brainstorm Cell Therapeutics, Inc.?
What is Brainstorm Cell Therapeutics, Inc. stock price today?
What was Brainstorm Cell Therapeutics, Inc. stock price yesterday?
What is the PE ratio of Brainstorm Cell Therapeutics, Inc.?
What is the Price-to-Book ratio of Brainstorm Cell Therapeutics, Inc.?
What is the 50-day moving average of Brainstorm Cell Therapeutics, Inc.?
How many employess does Brainstorm Cell Therapeutics, Inc. has?

Latest BCLI News

View

Advertisement|Remove ads.

Advertisement|Remove ads.